[EN] PYRROLO [3, 2 -E] [1,2,4] TRIAZOLO [1,5 -A] PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION [FR] DÉRIVÉS DE PYRROLO[3,2-E][1,2,4]TRIAZOLO[1,5-A]PYRIMIDINES EN TANT QU'INHIBITEURS DE L'ACTIVATION MICROGLIALE
PYRROLO [3,2-E] [1,2,4] TRIAZOLO [1,5-A] PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION
申请人:Scopes David
公开号:US20120289523A1
公开(公告)日:2012-11-15
The invention relates to novel compounds useful in the treatment and prophylaxis of disease. Compounds of the formula (I) wherein X is halogen, independently selected form chlorine and fluorine and n is 0, 1 or 2, and their pharmaceutically acceptable salts are useful in the treatment and prophylaxis of diseases caused by activation of microglia, particularly Alzheimer's disease.
PYRROLO [3, 2 -E][1,2,4]TRIAZOLO [1,5 -A]PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION
申请人:Senexis Limited
公开号:EP2488527A1
公开(公告)日:2012-08-22
[EN] PYRROLO [3, 2 -E] [1,2,4] TRIAZOLO [1,5 -A] PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION<br/>[FR] DÉRIVÉS DE PYRROLO[3,2-E][1,2,4]TRIAZOLO[1,5-A]PYRIMIDINES EN TANT QU'INHIBITEURS DE L'ACTIVATION MICROGLIALE
申请人:SENEXIS LTD
公开号:WO2011042496A1
公开(公告)日:2011-04-14
The invention relates to novel compounds useful in the treatment and prophylaxis of disease. Compounds of the formula (I) wherein X is halogen, independently selected form chlorine and fluorine and n is 0, 1 or 2. and their pharmaceutically acceptable salts are useful in the treatment and prophylaxis of diseases caused by activation of microglia, particularly Alzheimer's disease.